Cabergoline-induced pneumocephalus in a medically treated macroprolactinoma.
Internal Medicine Department, University of Texas Health Science Center at Houston, 6431 Fannin Street, MSB 1.134, Houston, Texas 77030, USA. jorge.d.machicadorivero@uth.tmc.edu
Jorge D
JD
Machicado
Jeena M
JM
Varghese
Philip R
PR
Orlander
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077465:Cabergoline; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D011007:Pneumocephalus / Q000139:chemically induced*; D015175:Prolactinoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline